Xipamide disposition liver cirrhosis pharmacokinetics sulfonamide-type diuretic xipamide patients liver cirrhosis ascites healthy control subjects oral administration mg diuretic blood ascites ratio area concentration-time curve AUC plasma ascitic fluid protein content respective compartments AUC plasma cirrhotic patients control subjects striking finding increase amount Ae parent drug main metabolite urine renal clearance xipamide patients liver cirrhosis AUC Ae plasma concentration direct bilirubin patients nonrenal drug clearance patients liver cirrhosis result blockade hepatobiliary excretion cholestatic conditions 